Widhalm G - Search Results

1

Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.

Neuhauser M, Roetzer T, Oberndorfer S, Kitzwoegerer M, Payer F, Unterluggauer JJ, Haybaeck J, Stockhammer G, Iglseder S, Moser P, Thomé C, Stultschnig M, Wuertz F, Brandner-Kokalj T, Weis S, Bandke D, Pichler J, Hutterer M, Krenosz KJ, Boehm A, Mayrbaeurl B, Hager-Seifert A, Kaufmann H, Dumser M, Reiner-Concin A, Hoenigschnabl S, Kleindienst W, Hoffermann M, Dieckmann K, Kiesel B, Widhalm G, Marosi C, Jaeger U, Hainfellner A, Hackl M, Hainfellner JA, Preusser M, Woehrer A. Neuhauser M, et al. Among authors: widhalm g. Acta Oncol. 2019 Jul;58(7):967-976. doi: 10.1080/0284186X.2019.1599137. Epub 2019 Apr 17. Acta Oncol. 2019. PMID: 30994047

2

Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.

Preusser M, Gelpi E, Rottenfusser A, Dieckmann K, Widhalm G, Dietrich W, Bertalanffy A, Prayer D, Hainfellner JA, Marosi C. Preusser M, et al. Among authors: widhalm g. J Neurooncol. 2008 Sep;89(2):211-8. doi: 10.1007/s11060-008-9608-3. Epub 2008 May 6. J Neurooncol. 2008. PMID: 18458820 Clinical Trial.

3

Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.

Widhalm G, Wolfsberger S, Preusser M, Fischer I, Woehrer A, Wunderer J, Hainfellner JA, Knosp E. Widhalm G, et al. J Neurosurg. 2009 Sep;111(3):563-71. doi: 10.3171/2008.4.17517. J Neurosurg. 2009. PMID: 18991501

4

O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?

Widhalm G, Wolfsberger S, Preusser M, Woehrer A, Kotter MR, Czech T, Marosi C, Knosp E. Widhalm G, et al. Cancer. 2009 Mar 1;115(5):1070-80. doi: 10.1002/cncr.24053. Cancer. 2009. PMID: 19156926 Free article. Clinical Trial.

5

5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.

Widhalm G, Wolfsberger S, Minchev G, Woehrer A, Krssak M, Czech T, Prayer D, Asenbaum S, Hainfellner JA, Knosp E. Widhalm G, et al. Cancer. 2010 Mar 15;116(6):1545-52. doi: 10.1002/cncr.24903. Cancer. 2010. PMID: 20108311 Free article.

6

Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.

Widhalm G, Krssak M, Minchev G, Wöhrer A, Traub-Weidinger T, Czech T, Asenbaum S, Marosi C, Knosp E, Hainfellner JA, Prayer D, Wolfsberger S. Widhalm G, et al. J Neurol Neurosurg Psychiatry. 2011 May;82(5):512-20. doi: 10.1136/jnnp.2010.205229. Epub 2010 Oct 22. J Neurol Neurosurg Psychiatry. 2011. PMID: 20971752

7

Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Widhalm G, Minchev G, Woehrer A, Preusser M, Kiesel B, Furtner J, Mert A, Di Ieva A, Tomanek B, Prayer D, Marosi C, Hainfellner JA, Knosp E, Wolfsberger S. Widhalm G, et al. Neurosurg Rev. 2012 Jul;35(3):381-91; discussion 391. doi: 10.1007/s10143-012-0374-5. Epub 2012 Mar 10. Neurosurg Rev. 2012. PMID: 22407140

8

Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.

Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate KH, Widhalm G, Knosp E, Breitschopf H, Berger J, Marosi C. Preusser M, et al. Among authors: widhalm g. Clin Neuropathol. 2012 Sep-Oct;31(5):352-60. doi: 10.5414/NP300488. Clin Neuropathol. 2012. PMID: 22541785

9

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors.

Flechl B, Ackerl M, Sax C, Dieckmann K, Crevenna R, Gaiger A, Widhalm G, Preusser M, Marosi C. Flechl B, et al. Among authors: widhalm g. J Neurooncol. 2012 Sep;109(2):331-9. doi: 10.1007/s11060-012-0897-1. Epub 2012 May 29. J Neurooncol. 2012. PMID: 22644537

10

Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients.

Keilani M, Krall C, Marosi C, Flechl B, Dieckmann K, Widhalm G, Marhold M, Crevenna R. Keilani M, et al. Among authors: widhalm g. Wien Klin Wochenschr. 2012 Jun;124(11-12):377-83. doi: 10.1007/s00508-012-0186-1. Epub 2012 Jun 12. Wien Klin Wochenschr. 2012. PMID: 22688136 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters